Mr. Bruce N. Kuhlik is an Executive Vice President, General Counsel of Merck & Co., Inc. He is responsible for legal, communications, and public policy functions and The Merck Company Foundation . Since January 2008 ? Executive Vice President and General Counsel, Merck & Co., Inc. ? responsible for legal, communications, and public policy functions and The Merck Company Foundation . Since August 2007 ? Senior Vice President and General Counsel, Merck & Co., Inc. ? responsible for legal, communications, and public policy functions and The Merck Company Foundation . since May 2005 ? Vice President and Associate General Counsel, Merck & Co., Inc. ? primary responsibility for the Company?s Vioxx litigation defense.
Executive VP and General Counsel
Age: 55 EVP Since 2009
The company has Return on Asset of 6.32 % which means that on every $100 spent on asset it made $6.32 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 11.21 % implying that it generated $11.21 on every 100 dollars invested.
The company has 20.57 B in debt with debt to equity (D/E) ratio of 0.37 which is OK given its current industry classification. Merck Co Inc has Current Ratio of 1.86 which is typical for the industry and considered as normal.
Entity SummaryMerck & Co., Inc. offer various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care solutions worldwide. Merck Co Inc [MRK] is traded on New York Stock Exchange in USA. It is located in Whitehouse Station, NJ and employs 82,000 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| MRK NYSE
Merck Co Inc
Currency: USD - US Dollar
Traded on New York Stock Exchange
Merck Co Inc has less than 16.16 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Merck price boundaries
Promote Merck and Bruce Kuhlik